key limitations of current treatment options for patients with mss-crc
Published 1 year ago • 177 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:46
dr. bendell on the treatment of microsatellite stable patients with crc
-
1:18
botensilimab and balstilimab in metastatic, pre-treated mss-crc
-
0:41
how can immunotherapies successfully target mss colorectal cancer?
-
1:06
what are the current treatment strategies for rectal cancer?
-
6:56
prior rt may potentially enhance treatment of mss-crc with regorafenib and pembrolizumab
-
1:29
com701 & nivolumab in patients with metastatic mss-crc & liver metastases
-
4:11
personalized, neoantigen-directed immunotherapy in patients with advanced mss-crc, gea and nsclc
-
5:44
a phase i/ii investigating the addition of io to the standard of care for patients with mss mcrc
-
24:05
what's new in colorectal cancer treatment? by michael hall, md, ms
-
4:57
non-surgical treatment options for patients with rectal cancer
-
1:55
the latest in targeted therapies for advanced colorectal cancer
-
15:12
initial management of metastatic crc in 2019
-
11:00
updates on treatment algorithms in metastatic crc in 2017 - left vs. right colon cancer
-
1:30
immunotherapy options in crc
-
1:47
updates on biomarkers of resistance to crc treatment
-
0:24
how can we incorporate checkpoint inhibition in microsatellite stable colorectal cancer?
-
31:04
what's new for colorectal cancer treatment?
-
6:11
immunotherapy in crc
-
49:42
rectal cancer: treatment, research and quality of life, facebook live event